A clinical snapshot of transdermal buprenorphine in pain management

European Journal of Pain Supplements

Volumn 1, Issue 1, 2007, Pages 74-77

  Russo, Marc A ^a   Wasiak, Jason ^b  

^a Australian Pain Research Centre   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

Buprenorphine; Opioids; Patient acceptability; Transdermal patches

Indexed keywords

BUPRENORPHINE; BUTRANS; MORPHINE; PLACEBO;

ANALGESIA; ANALGESIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONSTIPATION; DERMATITIS; DIAPHORESIS; DIZZINESS; DRUG DELIVERY SYSTEM; DRUG SAFETY; ERYTHEMA; HUMAN; NAUSEA AND VOMITING; NEUROPATHIC PAIN; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RESPIRATION DEPRESSION; SIDE EFFECT; SYSTEMIC CIRCULATION; XEROSTOMIA;

EID: 42649114139     PISSN: 17543207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1754-3207(08)60018-8     Document Type: Article

References (23)

1. Auriacombe M., Fatseas M., Dubernet J., Daulouede J., and Tignol J. French field experience with buprenorphine. Am J Addict 13 (2004) S17-S28
2. Bodkin J., Zornberg G., Lukas S., and Cole J. Buprenorphine treatment of refractory depression. J Clin Psychopharmacol 15 (1995) 49-57
3. Bohme K. Buprenorphine in a transdermal therapeutic system - a new option. Clin Rheumatol 21 (2002) S13-S16
4. Campora E., Merlini L., Pace M., Bruzzone M., Luzzani M., Gottlieb A., and Rosso R. The incidence of narcotic-induced emesis. J Pain Symptom Manage 6 (1991) 428-430
5. Dahan A., Yassen A., Bijl H., Romberg R., Sarton E., and Teppema L. Comparison of the respiratory effects of intravenous buprenorphine: comparison and fentanyl in humans and rats. Br J Anaesth 6 (1994) 825-834
6. Davis M. Buprenorphine in cancer pain. Support Care Cancer 13 (2005) 878-887
7. Emrich H., Voght P., Herz A., and Kissling W. Antidepressant effects of buprenorphine. Lancet 320 (1982) 709
8. Griessinger N., Sittl R., and Likar R. Transdermal buprenorphine in clinical practice - a post-marketing surveillance study in 13,179 patients. Curr Med Res Opin 21 (2005) 1147-1156
9. Heel R., Brogden R., Speight T., and Avery G. Buprenorphine: a review of its pharmacological properties and therapeutic efficacy. Drugs 17 (1979) 81-119
10. Huang P., Kehner G., Cowan A., and Liu-Chen L. Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist. J Pharmacol Exp Ther 297 (2001) 688-695
11. Johnson R., Fudala P., and Payne R. Buprenorphine: considerations for pain management. J Pain Symptom Manage 29 (2005) 297-326
12. Koppert W., Ihmsen H., Korber N., Wehrfritz A., Sittl R., Schmelz M., and Schuttler J. Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. Pain 118 (2005) 15-22
13. Kosten T., Morgan C., and Kosten T. Depressive symptoms during buprenorphine treatment of opioid abusers. J Subst Abuse Treat 7 (1990) 51-54
14. Likar R., and Sittl R. Transdermal buprenorphine for treating nociceptive and neuropathic pain: four case studies. Anesth Analg 100 (2005) 781-785
15. Likar R., Kayser H., and Sittl R. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, followup study in patients from three short-term clinical trials. Clin Ther 28 (2006) 943-952
16. Mongan L., and Calloway E. Buprenorphine responders. Biol Psychiatry 28 (1990) 1078-1080
17. Muriel C., Failde I., Mico J., Neira M., and Sanchez-Magro I. Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, openlabel, uncontrolled, prospective, observational clinical study. Clin Ther 27 (2005) 451-462
18. Sittl R., Griessinger N., and Likar R. Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial. Clin Ther 25 (2003) 150-168
19. Spyker D., Hale M., Karpow S., Miller J., and Reder R. Effectiveness of buprenorphine transdermal (BTDS) compared with oxycodone/acetaminophen and placebo in the treatment of patients with chronic back pain. Anesthesiology 95 (2001) A826
20. Spyker D., St. Ville J., Ledermann M., Munera C., and Wright C. Analgesic efficacy and safety of buprenorphine transdermal (BTDS) in patients with osteoarthritis. J Pain 2 Suppl 1 (2002) 12
21. Tallarida RJ. Drug Synergism and Dose-Effect Data Analysis. Boca Raton, Fl, Chapman & Hall/CRC, 2000.
22. Traynor J. G-protein coupling and efficacy of u-opioid agonists: relationship to behavioural efficacy. Revs Analgesia 8 (2004) 11-22
23. Zenz M. Long-term oral opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage 7 2 (1992) 69-77